Pharmacokinetics of obese adults: Not only an increase in weight

J Gouju, S Legeay - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Obesity is a pathophysiological state defined by a body mass index> 30 kg/m 2 and
characterized by an adipose tissue accumulation leading to an important weight increased …

Obesity and its cardiovascular effects

C Ortega‐Loubon, M Fernández‐Molina… - Diabetes/metabolism …, 2019 - Wiley Online Library
Obesity is described in terms of body fat percentage or body mass index (BMI), despite the
fact that these measures do not give full insight about the body fat distribution. It is presently …

Overweight and obesity in military personnel: sociodemographic predictors

TJ Smith, BP Marriott, L Dotson, GP Bathalon… - …, 2012 - Wiley Online Library
In the United States, nationally representative civilian studies have shown that BMI is
associated with select sociodemographic characteristics. Active‐duty military personnel are …

Single-pill fixed-dose drug combinations to reduce blood pressure: the right pill for the right patient

R Sarzani, G Laureti, A Gezzi… - … in Chronic Disease, 2022 - journals.sagepub.com
Arterial hypertension is one of the major causes of cardiovascular morbidity and mortality
worldwide. Effective and sustained reduction in blood pressure is essential to reduce …

Национальные рекомендации по определению риска и профилактике внезапной сердечной смерти

АВ Ардашев, ЕВ Шляхто, ГП Арутюнов… - Клиническая …, 2012 - cyberleninka.ru
Смертность от сердечнососудистых заболе ваний в России является одной из
наиболее высоких в мире и составляет 1462 на 100 000 жителей в год [1]. Основные …

Anti-inflammatory γ-and δ-tocotrienols improve cardiovascular, liver and metabolic function in diet-induced obese rats

WY Wong, LC Ward, CW Fong, WN Yap… - European journal of …, 2017 - Springer
Purpose This study tested the hypothesis that γ-and δ-tocotrienols are more effective than α-
tocotrienol and α-tocopherol in attenuating the signs of diet-induced metabolic syndrome in …

Non-alcoholic fatty liver disease with and without metabolic syndrome: different long-term outcomes

AJ Käräjämäki, R Bloigu, H Kauma, YA Kesäniemi… - Metabolism, 2017 - Elsevier
Background Non-alcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS) are
both shown to increase the risk of cardiovascular diseases and type 2 diabetes. However …

Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure

BA Alhafez, CJ Lavie, RV Milani… - Current Opinion in …, 2021 - journals.lww.com
Interactions of hypertension, obesity, left ventricular hype... : Current Opinion in Cardiology
Interactions of hypertension, obesity, left ventricular hypertrophy, and heart failure : Current …

Национальные рекомендации по определению риска и профилактике внезапной сердечной смерти (сокращённая версия)

ЕВ Шляхто, ГП Арутюнов… - Архивъ внутренней …, 2013 - cyberleninka.ru
Представленные рекомендации разработаны на основе современных достижений
отечественных и зарубежных специалистов, рассматриваются вопросы …

Self-reported adherence among individuals at high risk of metabolic syndrome: effect of knowledge and attitude

EA Alefishat, RK Abu Farha, MM Al-Debei - Medical Principles and …, 2017 - karger.com
Objective: This study aimed to evaluate factors that affect adherence in individuals at high
risk of metabolic syndrome, with a focus on knowledge and attitude effect. Subjects and …